Recognition and functional activation of the human IgA receptor (FcαRI) by C-reactive protein

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 12, 2011, Pages 4974-4979

  Lu, Jinghua ^a   Marjon, Kristopher D ^b   Marnell, Lorraine L ^b,c   Wang, Ruipeng ^a   Mold, Carolyn ^b   Du Clos, Terry W ^b,c   Sun, Peter ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c VA Medical Center   (United States)

Author keywords

Acute phase protein; CD89; Serum amyloid P component

Indexed keywords

C REACTIVE PROTEIN; CD16 ANTIGEN; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; PENTRAXIN; POTEIN FCALPHARI; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CROSS LINKING; DEGRANULATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD; BINDING SITES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMPLEMENT C1Q; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MUTATION; NEUTROPHILS; PHAGOCYTOSIS; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, FC; RECEPTORS, IGG; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953185054     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1018369108     Document Type: Article

References (34)

1. Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 117:104-111. (Pubitemid 41407719)
2. Kaplan MH, Volanakis JE (1974) Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 112:2135-2147.
3. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW (1999) The major receptor for C-reactive protein on leukocytes is Fcgamma receptor II. J Exp Med 190:585-590. (Pubitemid 29395386)
4. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW (1995) C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol 155:2185-2193.
5. Mold C, Baca R, Du Clos TW (2002) Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors. J Autoimmun 19:147-154. (Pubitemid 35341864)
6. Lu J, et al. (2008) Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456:989-992.
7. Rodriguez W, et al. (2007) C-reactive protein-mediated suppression of nephrotoxic nephritis: Role of macrophages, complement, and Fcgamma receptors. J Immunol 178:530-538. (Pubitemid 46033637)
8. Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD (2001) The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem 276:16469-16477.
9. Sondermann P, Huber R, Oosthuizen V, Jacob U (2000) The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406:267-273. (Pubitemid 30604397)
10. Monteiro RC, Van De Winkel JG (2003) IgA Fc receptors. Annu Rev Immunol 21: 177-204. (Pubitemid 37174530)
11. Herr AB, Ballister ER, Bjorkman PJ (2003) Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1- Fc. Nature 423:614-620. (Pubitemid 36713216)
12. Maxwell KF, et al. (1999) Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol 6:437-442. (Pubitemid 29218012)
13. Zhang Y, et al. (2000) Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity 13:387-395.
14. Kremer EJ, et al. (1992) The gene for the human IgA Fc receptor maps to 19q13.4. Hum Genet 89:107-108.
15. Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT (2002) Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 23:81-88. (Pubitemid 34310149)
16. Wu J, et al. (2007) FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA. J Immunol 178:3973-3982. (Pubitemid 46417668)
17. Singh U, et al. (2008) Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J Lipid Res 49:1015-1023.
18. Devaraj S, Dasu MR, Singh U, Rao LV, Jialal I (2009) C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis 203:67-74.
19. Gaboriaud C, et al. (2003) The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 278: 46974-46982. (Pubitemid 37452280)
20. Bang R, et al. (2005) Analysis of binding sites in human C-reactive protein for FcgammaRI, FcgammaRIIA, and C1q by site-directed mutagenesis. J Biol Chem 280: 25095-25102. (Pubitemid 40934601)
21. Ouadrhiri Y, Pilette C, Monteiro RC, Vaerman JP, Sibille Y (2002) Effect of IgA on respiratory burst and cytokine release by human alveolar macrophages: Role of ERK1/ 2 mitogen-activated protein kinases and NF-kappaB. Am J Respir Cell Mol Biol 26: 315-332. (Pubitemid 34170058)
22. Bharadwaj D, Mold C, Markham E, Du Clos TW (2001) Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 166: 6735-6741. (Pubitemid 32467217)
23. Mold C, Du Clos TW (2006) C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors. J Immunol 176:7598-7604. (Pubitemid 43853054)
24. Pasquier B, et al. (2005) Identification of FcalphaRI as an inhibitory receptor that controls inflammation: Dual role of FcRgamma ITAM. Immunity 22:31-42. (Pubitemid 40143449)
25. Graham TE, et al. (1998) MEK and ERK activation in Ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling. J Immunol 161:6733-6744. (Pubitemid 28562216)
26. Brown MA, et al. (1987) B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50:809-818.
27. Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL (1994) Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem 269:29697-29703.
28. Mócsai A, et al. (2000) Kinase pathways in chemoattractant-induced degranulation of neutrophils: The role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol 164:4321-4331. (Pubitemid 30215095)
29. Lang ML, Shen L, Wade WF (1999) Gamma-chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor Fc alpha R. J Immunol 163: 5391-5398.
30. Hostoffer RW, Krukovets I, Berger M (1993) Increased Fc alpha R expression and IgA-mediated function on neutrophils induced by chemoattractants. J Immunol 150:4532-4540. (Pubitemid 23133730)
31. Bliss SK, Marshall AJ, Zhang Y, Denkers EY (1999) Human polymorphonuclear leukocytes produce IL-12, TNF-alpha, and the chemokines macrophage-inflammatory protein-1 alpha and -1 beta in response to Toxoplasma gondii antigens. J Immunol 162:7369-7375. (Pubitemid 29277713)
32. Cassatella MA (1999) Neutrophil-derived proteins: Selling cytokines by the pound. Adv Immunol 73:369-509.
33. Shen L, Collins JE, Schoenborn MA, Maliszewski CR (1994) Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. J Immunol 152:4080-4086. (Pubitemid 24111080)
34. Grossetête B, et al. (1998) Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: Evidence for a negative regulatory role of serum IgA. Kidney Int 53:1321-1335. (Pubitemid 28316894)